Back to Susquehanna International Group, LLP Susquehanna International Group, LLP

JSPRJSPR

Showing 8 of 10 quarters

Position history for Susquehanna International Group, LLPSusquehanna International Group, LLP's holdings in Jasper Therapeutics, Inc.

No. Susquehanna International Group exited its JSPR (Jasper Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 11,149 shares worth $9,769. Susquehanna International Group already held JSPR in its Q1 2024 13F, the earliest on record, and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$385,981

Total Shares Change

-20,520

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$0.42
0
2026-Q1
Decreased
11,149
-89.4%
$9,7690.0%$0.88
0
2025-Q4
Increased
104,787
+194.4%
$191,7600.0%$1.83
25
2025-Q3
Decreased
35,592
-41.5%
$84,7090.0%$2.38
0
2025-Q2
Increased
60,886
+278.4%
$337,9170.0%$5.55
26
2025-Q1
Decreased
16,091
-29.5%
$69,1910.0%$4.30
0
2024-Q4
Increased
22,814
+11.2%
$487,7630.0%$21.38
27
2024-Q3
New
20,520
—
$385,9810.0%$18.83
33

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used